The set point of parathyroid hormone stimulation by calcium is normal in progressive renal failure

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 11, 1998, Pages 3839-3844

  Cardinal, H ^a   Brossard, J H ^a   Roy, L ^a   Lepage, R ^a   Rousseau, L ^a   D'Amour, P ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; PARATHYROID HORMONE;

ADULT; AGED; ARTICLE; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; HUMAN; KIDNEY FAILURE; MALE; PARATHYROID FUNCTION; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROID HORMONE RELEASE; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; REGULATORY MECHANISM; VITAMIN BLOOD LEVEL;

EID: 0031765001     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.83.11.5256     Document Type: Article

References (35)

1. Brown EM, Wilson RE, Eastman RC, Pallotta J, Marynick SP. 1982 Abnormal regulation of parathyroid hormone release by calcium in secondary hyperparathyroidism due to chronic renal failure. J Clin Endocrinol Metab. 54:172-179.
2. D'Amour P, Palardy J, Bashali G, Malette LE, De Léan A, Lepage R. 1992 Modulation of circulating parathyroid hormone immunoheterogeneity in man by ionized calcium concentration. J Clin Endocrinol Metab. 74:525-532.
3. Ramirez JA, Goodman WG, Gombein J, et al. 1993 Direct in vivo comparison of calcium-regulated parathyroid hormone secretion in normal volunteers and patients with secondary hyperparathyroidism. J Clin Endocrinol Metab. 76:1489-1494.
4. Dunlay R, Rodriguez M, Felsenfeld AJ, Llach F. 1989 Direct inhibitory effect of calcitriol on parathyroid function (sigmoidal curve) in dialysis. Kidney Int. 36:1093-1098.
5. Rodriguez M, Felsenfeld AJ, Williams C, Pederson JA, Llach F. 1991 The effect of long-term intravenous calcitriol administration on parathyroid function in hemodialysis patients. J Am Soc Nephrol. 2:1014-1020.
6. Felsenfeld AJ, Rodriguez M, Dunlay R, Llach F. 1991 A comparison of parathyroid-gland function in haemodialysis patients with different forms of renal osteodystrophy. Nephrol Dial Transplant. 6:244-251.
7. Ramirez JA, Goodman WG, Belin TR, Gales B, Segre GV, Salusky IB. 1994 Calcitriol therapy and calcium-regulated PTH secretion in patients with secondary hyperparathyroidism. Am J Physiol. 267:E961-E967.
8. Combe C, Aparicio M. 1994 Phosphorus and protein restriction and parathyroid function in chronic renal failure. Kidney Int. 46:1381-1386.
9. Caravaca F, Cubero JJ, Jimenez F, et al. 1995 Effect of the mode of calcitriol administration on PTH-ionized calcium relationship in uraemic patient with secondary hyperparathyroidism. Nephrol Dial Transplant. 10:665-667.
10. Sanchez CP, Goodman WG, Ramirez JA, et al. 1995 Calcium-regulated parathyroid hormone secretion in adynamic renal osteodystrophy. Kidney Int. 48:838-843.
11. Felsenfeld AJ, Jara A, Pahl M, Bover J, Rodriguez M. 1995 Differences in the dynamics of parathyroid hormone secretion in hemodialysis patients with marked secondary hyperparathyroidism. J Am Soc Nephrol. 6:1371-1378.
12. Goodman WG, Beun T, Gales B, Jüppner H, Segre GV, Salusky IB. 1995 Calcium-regulated parathyroid hormone release in patients with mild or advanced secondary hyperparathyroidism. Kidney Int. 48:1553-1558.
13. Pahl M, Jara A, Bover J, Rodriguez M, Felsenfeld AJ. 1996 The set point of calcium and the reduction of parathyroid hormone in hemodialysis patients. Kidney Int. 49:226-231.
14. Ouseph R, Leiser JD, Moe SM. 1996 Calcitriol and the parathyroid hormone-ionized calcium curve: a comparison of methodologic approaches. J Am Soc Nephrol. 7:497-505.
15. Madsen JC, Rasmussen AQ, Ladefoged SD, Schwarz P. 1996 Parathyroid hormone secretion in chronic renal failure. Kidney Int. 50:1700-1705.
16. Brossard JH, Roy L, Lepage R, Gascon-Barré M, D'Amour P. 1997 Intravenous 1,25(OH)2D therapy increases the intact parathyroid hormone secretion set point in hemodialysis patients. Miner Electrolyte Metab. 23:25-32.
17. Rodriguez M, Caravaca F, Fernandez E, et al. 1997 Evidence for both abnormal set point of PTH stimulation by calcium and adaptation to serum calcium in hemodialysis patients with hyperparathyroidism. J Bone Miner Res. 12:347-355.
18. Malberti F, Surian M, Cosci P. 1992 Effect of chronic intravenous calcitriol on parathyroid function and set point of calcium in dialysis patients with refractory secondary hyperparathyroidism. Nephrol Dial Transplant. 7:822-828.
19. Martinez I, Saracho R, Montenegro J, Llach F. 1996 A deficit of calcitriol synthesis may not be the initial factor in the pathogenesis of secondary hyperparathyroidism. Nephrol Dial Transplant. 11:22-28.
20. Messa P, Vallone C, Mioni G, et al. 1994 Direct in vivo assessment of parathyroid hormone-calcium relationship curve in renal patients. Kidney Int. 46:1713-1720.
21. Brossard JH, Whittom S, Lepage R, D'Amour P. 1993 Carboxylterminal fragments of parathyroid hormone are not secreted preferentially in primary hyperparathyroidism as they are in other causes of hypercalcemia. J Clin Endocrinol Metab. 77:413-419.
22. Cardinal H, Roy L, Rousseau L, Lepage R, D'Amour P, Brossard JH. 1998 Factors associated with secondary hyperparathyroidism in patients with various degrees of renal failure. Proc of the 80th Annual Meeting of The Endocrine Society, New Orleans, LA, 1998, pp 494 (Abstract P3-532).
23. Nussbaum SR, Zahradnik RJ, Lavigne JR, et al. 1987 Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia. Clin Chem. 33:1364-1367.
24. Ratcliffe WA, Heath DA, Ryan M, Jones SR. 1989 Performance and diagnostic application of a two-site immunoradiometric assay for parathyrin in serum. Clin Chem. 35:1957-1961.
25. Lepage R, Roy L, Brossard JH, et al. 1998 A non-(1-84) circulating PTH fragment interferes significantly with intact PTH commercial assay measurements in uremic samples. Clin Chem. 44:805-809.
26. Brossard JH, Cloutier M, Roy L, Lepage R, Gascon-Barré M, D'Amour P. 1996 Accumulation of a non-(1-84) molecular form of parathyroid hormone (PTH) detected by intact parathyroid hormone assay in renal failure: importance in the interpretation of PTH values. J Clin Endocrinol Metab. 81:3923-3929.
27. Brown EM. 1983 Four-parameters model of the sigmoidal relationship between parathyroid hormone release and extracellular calcium concentration in normal and abnormal parathyroid tissue. J Clin Endocrinol Metab. 56:572-581.
28. Pitts TO, Piraino BH, Mitro R, et al. 1988 Hyperparathyroidism and 1,25-dihydroxyvitamin D deficiency in mild, moderate and severe renal failure. J Clin Endocrinol Metab. 67:876-881.
29. Reichel H, Deibert B, Schmidt-Gayk H, Ritz E. 1991 Calcium metabolism in early chronic renal failure: implications for the pathogenesis of hyperparathyroidism. Nephrol Dial Transplant. 6:162-169.
30. St. John A, Thomas MB, Davies CP, et al. 1992 Determinants of intact parathyroid hormone and free 1,25-dihydroxyvitamin D levels in mild and moderate renal failure. Nephron. 61:422-427.
31. Fajtova VT, Sayegh MH, Hickey N, Aliabadi F, Lazarus JM, Le Boff MS. 1995 Intact parathyroid hormone levels in renal insufficiency. Calcif Tissue Int. 57:329-335.
32. Thomas MK, Lloyd-Jones DM, Thadham RI, et al. 1998 Hypovitaminosis D in medical in patients. New Engl J Med. 338:77-783.
33. Brent GA, Le Boff MS, Seely EW, Conlin PR, Brown EM. 1988 Relationship between the concentration and rate of change of calcium and serum intact parathyroid hormone levels in normal humans. J Clin Endocrinol Metab. 67:944-950.
34. Aguilera-Tejero E, Sanchez J, Almaden Y, Mayer-Valor R, Rodriguez M, Felsenfeld AJ. 1996 Hysteresis of the PTH-calcium curve during hypocalcemia in the dog: effect of the rate and linearity of calcium decrease and sequential episodes of hypocalcemia. J Bone Miner Res. 11:1226-1233.
35. Felsenfeld AJ, Ross D, Rodriguez M. 1991 Hysteresis of parathyroid hormone response to hypocalcemia in hemodialysis patients with low turnover aluminum bone disease. J Am Soc Nephrol. 2:1136-1143